-
3740 E Southern Ave, Ste 210
Mesa, AZ 85206 -
Monday–Friday, 9:00 AM – 6:00 PM MST
by appointment only -
Saturday
By Appointment -
Sunday
Closed
Spravato vs IV ketamine is a question many adults ask after reading about newer depression treatments online. IV stands for intravenous, which means a medicine is given through a small tube placed in a vein. Spravato is a nasal spray made from esketamine, and it is a different product from an infusion.
This guide explains how the two are related, how each is given, and what to ask a provider. You can also see how treatment-resistant depression care in Mesa is organized locally. Understanding the basics makes it easier to separate marketing language from medical facts.
Depression that does not ease with several medicines can feel draining. Many people then look for something new. Ketamine care shows up often in those searches. Many sites use the same words for treatments that are quite different.
That overlap causes confusion. One option is a nasal spray with its own approval and its own rules. The other is a medicine given through a vein, often described under the broader name ketamine therapy. Comparing them fairly means looking at what each one is, how it is given, and who oversees it.
This guide treats Spravato vs IV ketamine as a question of fit, not a contest. A treatment that suits one person’s health and routine may not suit another’s. Knowing the differences ahead of time helps you ask better questions and avoid rushed choices.
Ketamine is an older medicine first used as an anesthetic, which is a drug that blocks pain during surgery. Esketamine is closely related to it. According to Johns Hopkins Medicine, esketamine is more potent, meaning stronger. A lower dose can be used, and it may cause fewer side effects in theory.
The same source says esketamine must be used with a standard antidepressant. It also explains what treatment-resistant depression means. You have tried at least two other antidepressants, for at least six weeks each, without enough relief.
The biggest difference is approval. According to the National Institute of Mental Health (NIMH), doctors began prescribing ketamine off-label for treatment-resistant depression. In 2019, the U.S. Food and Drug Administration (FDA) gave full approval to esketamine for that use.
The same page adds a practical point. Because ketamine must be given by IV, it can be expensive and inconvenient. Esketamine was made in a form that does not need an IV. This shift is one reason the Spravato vs IV ketamine discussion is so common.
Off-label does not mean unsafe by definition. It means the use was not formally approved, so providers lean on other evidence and their own judgment.
Spravato is not a take-home product. According to Johns Hopkins Medicine, it has to be given in a clinic setting. You stay there under a doctor’s observation until possible side effects have passed. The first month usually follows a twice-weekly pattern, then tapers to a maintenance schedule.
Our page on Spravato treatment for treatment-resistant depression explains how this care is evaluated and delivered. Patients often find it helpful to know the routine before a first visit.
Esketamine can change how you perceive things for a short time. Staff watch you until that passes. This is part of the safety design, not a sign that something went wrong.
IV treatment follows a different routine. According to Cleveland Clinic, ketamine therapy is given by IV or nasal spray, under medical supervision. A visit usually lasts two to three hours, depending on the type.
With an infusion, a provider places the IV and starts the medicine. Staff then monitor you during the session and afterward. Because the exact schedule can vary from one clinic to another, ask each provider to explain theirs in writing.
Spravato vs IV ketamine also differs in who does what. With the nasal spray, you give yourself the dose while staff observe. With an infusion, the clinic starts and manages the delivery through the IV. Neither is a casual visit, and both call for planning around the time involved.
Both approaches need close checks. The Cleveland Clinic page says your care team checks your vital signs, such as blood pressure and pulse, during the session. They keep checking for 30 to 120 minutes afterward. Common side effects include restlessness, blurred vision, feeling detached, high blood pressure, and nausea or vomiting.
The same source notes that researchers are still studying the long-term safety of ketamine for depression. The page does not break down side effects by delivery method, so be cautious about claims that one form is free of them. You can read more in our article on Spravato side effects.
Tell the provider about every medicine and supplement you use, and about any alcohol or other substances. Some mixes cause sleepiness and can be unsafe, so honest answers protect you. A careful provider will ask before any session.
A medical review before treatment is a basic safeguard. If a provider skips it, treat that as a warning sign.
Practical details often decide what is realistic. NIMH calls the need for an IV expensive and inconvenient, so many people compare how each option fits their lives. Prices vary, so ask each provider directly.
Coverage also differs. An approved medicine may be reviewed by an insurer differently than an off-label service. Our article on Spravato insurance coverage explains the terms and questions to bring to your plan. Each plan sets its own rules, so confirm your own benefits.
No. Spravato contains esketamine, a more potent, related form. It is a nasal spray with its own approval, not a version of an infusion.
NIMH says physicians prescribe ketamine off-label for treatment-resistant depression. Esketamine is the form that received FDA approval for it.
The two differ in approval, delivery, checks, and cost. Those differences shape your schedule, safety steps, and insurance questions.
No. It has to be given in a clinic, and you stay under observation until potential side effects pass.
No. Responses vary, and long-term safety is still being studied. A provider tracks your progress and adjusts the plan.
Yes. A full evaluation reviews your history and medicines before any plan is chosen.
Neither option is right for everyone. The better fit depends on your health history, your past medicines, your schedule, and your budget. A provider who explains the difference clearly and without pressure is a good sign.
Our page on psychiatric evaluations and medication management explains how providers review your history and plan next steps. Bring a list of past antidepressants and your questions. Knowing the Spravato vs IV ketamine basics helps you join that talk with confidence.
Disclaimer: This article is for educational purposes only and does not replace professional medical advice, diagnosis, or treatment. It does not recommend or evaluate any specific clinic or provider. Always speak with a qualified healthcare provider about your individual situation. If you are in crisis or having thoughts of harming yourself, contact your local emergency services or a crisis line right away.